Peripheral gating of mechanosensation by glial diazepam binding inhibitor

Li, X, Prudente, AS, Prato, V, Guo, X, Hao, H, Jones, F ORCID: https://orcid.org/0000-0003-1636-0054, Figoli, S, Mullen, P, Wang, Y, Tonnello, R, Lee, SH, Shah, S, Maffei, B, Berta, T, Du, X and Gamper, N (2024) Peripheral gating of mechanosensation by glial diazepam binding inhibitor. The Journal of Clinical Investigation, 134 (16). e176227. ISSN 0021-9738

Preview

Published Version Available under License Creative Commons Attribution. Download (12MB) | Preview

Abstract

We report that diazepam binding inhibitor (DBI) is a glial messenger mediating satellite glia-sensory neuron crosstalk in the dorsal root ganglion (DRG). DBI is highly expressed in satellite glia cells (SGCs) of mice, rat and human, but not in sensory neurons or most other DRG-resident cells. Knockdown of DBI results in a robust mechanical hypersensitivity without major effects on other sensory modalities. In vivo overexpression of DBI in SGCs reduces sensitivity to mechanical stimulation and alleviates mechanical allodynia in neuropathic and inflammatory pain models. We further show that DBI acts as an unconventional agonist and positive allosteric modulator at the neuronal GABAA receptors, particularly strongly effecting those with a high-affinity benzodiazepine binding site. Such receptors are selectively expressed by a subpopulation of mechanosensitive DRG neurons and these are also more enwrapped with DBI-expressing glia, as compared to other DRG neurons, suggesting a mechanism for specific effect of DBI on mechanosensation. These findings identified a new, peripheral neuron-glia communication mechanism modulating pain signalling, which can be targeted therapeutically.